` 600739 (Liaoning Cheng Da Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

600739
vs
Shanghai Composite

Over the past 12 months, has underperformed Shanghai Composite, delivering a return of -15% compared to the Shanghai Composite's 12% growth.

Stocks Performance
600739 vs Shanghai Composite

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
600739 vs Shanghai Composite

Loading
600739
Shanghai Composite
Difference

Performance By Year
600739 vs Shanghai Composite

Loading
600739
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Liaoning Cheng Da Co Ltd vs Peers

Shanghai Composite
600739
GPC
POOL
LKQ
DIE
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Liaoning Cheng Da Co Ltd
Glance View

Market Cap
14.7B CNY
Industry
Distributors

Liaoning Cheng Da Co Ltd stands as a significant player in the landscape of Chinese conglomerates, weaving a diverse portfolio that strategically aligns with the economic growth patterns of the region. Founded in the bustling province of Liaoning, the company epitomizes a model of diversified investment, underpinning its operations with a well-considered spread across various sectors. Initially, it carved a niche in the trading business, leveraging the abundant natural resources and industrial outputs of its home province to build a steady stream of revenue. This foundation allowed Cheng Da to expand into pharmaceuticals, real estate, and financial investments, each segment contributing distinctively to the company’s overall robustness. Cheng Da’s pharmaceutical business has emerged as a cornerstone, thriving amidst the rising demand for healthcare products in China. This arm of the company is particularly adept in leveraging advanced research methodologies combined with traditional Chinese medicine, thus creating a distinctive edge in both domestic and international markets. Meanwhile, its real estate ventures capably ride the wave of urbanization in China, focusing on premium residential and commercial properties, enhancing the urban landscape while adding to its financial metrics. By sitting at the crossroads of critical sectoral developments and maintaining a keen eye on expansive opportunities, Liaoning Cheng Da Co Ltd astutely navigates the intricate dance of market dynamics, thus cementing its place as a formidable entity in the economic engine of China.

Intrinsic Value
14.52 CNY
Undervaluation 34%
Intrinsic Value
Price
L
Back to Top